✦ LIBER ✦

Defining post-stroke recovery: implications for design and interpretation of drug trials

✍ Scribed by Pamela W Duncan; Sue Min Lai; John Keighley

Book ID: 117186936
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 116 KB
Volume: 39
Category: Article
ISSN: 0028-3908
DOI: 10.1016/s0028-3908(00)00003-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The post-rigor structure of myosin VI an

The post-rigor structure of myosin VI and implications for the recovery stroke

✍ Ménétrey, Julie; Llinas, Paola; Cicolari, Jérome; Squires, Gaëlle; Liu, Xiaoyan; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 623 KB

Rationale and Design of the EPISTEME Tri

Rationale and Design of the EPISTEME Trial: Efficacy of Post-Stroke Intensive Rosuvastatin Treatment for Aortogenic Embolic Stroke

✍ Ueno, Yuji; Yamashiro, Kazuo; Tanaka, Yasutaka; Watanabe, Masao; Shimada, Yoshia 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 238 KB

HISTORICAL PERSPECTIVE ON DRUG-PLACEBO D

HISTORICAL PERSPECTIVE ON DRUG-PLACEBO DIFFERENCES: IMPLICATIONS FOR GENERALIZABILITY OF RESULTS AND FUTURE TRIAL DESIGN

✍ Larry Alphs 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Reproducibility of home, ambulatory, and

Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy

✍ George S Stergiou; Nikolaos M Baibas; Alexandra P Gantzarou; Irini I Skeva; Chry 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 58 KB

Reproducibility of home, ambulatory, and

Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy

✍ George S Stergiou; Nicolaos M Baibas; Alexandra P Gantzarou; Irini I Skeva; Chry 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 38 KB

Stage migration and increasing proportio

Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients : Implications for clinical trial design and interpretation

✍ Sujata Patil; Nicole Ishill; John Deluca; Robert J. Motzer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

## Abstract ## BACKGROUND: The Memorial Sloan‐Kettering Cancer Center risk model classifies patients with metastatic renal cell carcinoma (RCC) by 5 pretreatment features as favorable, intermediate, and poor risk. The number of Memorial Sloan‐Kettering Cancer Center patients in each risk group was